Commonly known as a “silent killer” because it can have few symptoms, chronic hepatitis B can lead to liver damage or cancer, is not well studied and as a research area remains underfunded. Many living with it face significant social stigma, which discourages getting tested and leaves patients isolated and unwilling to open up about their experiences.
The silence hits immigrant communities the hardest, a phenomenon advocates have spent decades trying to fix. Asian Americans are disproportionately affected by hepatitis B, especially by chronic infections. Years of community work have led to better outreach, and new efforts like universal screening are starting to build momentum.
